Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Maggi

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Plos One|October 1, 2014
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studiesRoberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, et al.
Journal of Perinatal Medicine|December 2, 2021
Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disordersCecilia Cavalli, Claudia Maggi, Sebastiana Gambarini, et al.
Critical Reviews in Oncology/Hematology|June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysisFilippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 26, 2023
Sleep-disordered breathing and pregnancy outcomes: The impact of maternal oxygen saturationRossana Orabona, Luciano Corda, Jordan Giordani, et al.
Nutrition and Cancer|November 5, 2020
Role of Diet in the Management of Carcinoid Syndrome: Clinical Recommendations for Nutrition in Patients with Neuroendocrine TumorsSalvatore Artale, Sabrina Barzaghi, Nunziata Grillo, et al.
World Journal of Clinical Cases|December 18, 2014
Role of MGMT as biomarker in colorectal cancerAlessandro Inno, Giuseppe Fanetti, Maria Di Bartolomeo, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2015
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyMaria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, et al.
European Journal of Radiology|May 16, 2008
Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions?Laura Ballesio, Sara Savelli, Marco Angeletti, et al.
Oncology|June 14, 2014
TP53 mutations in advanced colorectal cancer: the dark side of the moonFilippo Pietrantonio, Pamela Biondani, Federica Perrone, et al.
Breast Cancer Research and Treatment|June 16, 2017
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective studyClaudio Vernieri, Monica Milano, Alessia Mennitto, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Plos One|October 1, 2014
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studiesRoberto Iacovelli, Filippo Pietrantonio, Alessio Farcomeni, et al.
Journal of Perinatal Medicine|December 2, 2021
Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disordersCecilia Cavalli, Claudia Maggi, Sebastiana Gambarini, et al.
Critical Reviews in Oncology/Hematology|June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysisFilippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 26, 2023
Sleep-disordered breathing and pregnancy outcomes: The impact of maternal oxygen saturationRossana Orabona, Luciano Corda, Jordan Giordani, et al.
Nutrition and Cancer|November 5, 2020
Role of Diet in the Management of Carcinoid Syndrome: Clinical Recommendations for Nutrition in Patients with Neuroendocrine TumorsSalvatore Artale, Sabrina Barzaghi, Nunziata Grillo, et al.
World Journal of Clinical Cases|December 18, 2014
Role of MGMT as biomarker in colorectal cancerAlessandro Inno, Giuseppe Fanetti, Maria Di Bartolomeo, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2015
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyMaria Di Bartolomeo, Andrea Ciarlo, Alessandro Bertolini, et al.
European Journal of Radiology|May 16, 2008
Breast MRI: Are T2 IR sequences useful in the evaluation of breast lesions?Laura Ballesio, Sara Savelli, Marco Angeletti, et al.
Oncology|June 14, 2014
TP53 mutations in advanced colorectal cancer: the dark side of the moonFilippo Pietrantonio, Pamela Biondani, Federica Perrone, et al.
Breast Cancer Research and Treatment|June 16, 2017
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective studyClaudio Vernieri, Monica Milano, Alessia Mennitto, et al.
Pageof 4